Still reading thought the comments. Seems like we
Post# of 148292
Anyways people are hung up on the serve trial readout. Ever thought that maybe the FDA only wants to see the results from the mild to moderate because the FDA can clearly see its stopping COVID in its tracks. So why worry about the serve trial they can still fill the trial up while saving some lives because they can’t do EINDs anymore.
I think the serve is a last resort to adding more data. To me it appears that everyone in the mild to moderate has recovered. I think when Leronlimab is given early enough it stops it in its track.... Now we wait for the results which should be in a few weeks. “They should be dramatic” Dr B Patterson.
I know is I wish I had more balls to drop another 10k tmw to buy more shares. But then I look at the shares I have now and realize more and more everyday that I can’t even place a value on them below 100, which will be plenty of money down the road.
Beside the money I’m so happy just to be invested in something that can possibly cure HIV. I don’t know anyone who has HIV, but I always wish that someday that we would find a cure for it and get somewhere with cancer. I’m so happy to be a small part of this company.
Anyways enough with my rant!